Leading the Way in Life Science Technologies

GEN Exclusives

More »

Feature Articles

More »

For full access to this article login to GEN Select now.

October 15, 2017 (Vol. 37, No. 18)

Cancer Immunotherapy Spurs Work on Better Animal Models

<i>GEN</i> Spoke to Several Researchers on Advances in Engineered Animal Models Used to Study Novel Cancer Im-munotherapies

  • Figure 1. The use of super-immunocompromised mouse models enables the expression of human immune cells in mice engrafted with human tumors. Those models can be used to study the effectiveness of novel immunotherapeutic strategies to treat cancer, such as monoclonal antibody-based immune checkpoint inhibition. Charles River

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.